List of Contributors | p. v |
Introduction | p. ix |
Overview of Vaccine Strategies | p. 1 |
Designing Vaccines in the Era of Genomics | p. 21 |
New Analytical Approaches for Measuring Protective Capacity of Antibodies | p. 55 |
New Frontiers in the Chemistry of Glycoconjugate Vaccines | p. 69 |
Bacterial Protein Toxins Used in Vaccines | p. 109 |
Adjuvants | p. 139 |
Mucosal Vaccines | p. 171 |
Intralymphatic Vaccination | p. 211 |
The First Vaccine Obtained Through Reverse Vaccinology: the Serogroup B Meningococcus Vaccine | p. 225 |
Vaccines for Neglected Diseases | p. 243 |
Vaccines to Combat Pseudomonas aeruginosa Infections in Immunocompromised Patients | p. 253 |
Nosocomial Infections: Staphylococcus aureus | p. 269 |
Towards the Development of a Universal Vaccine Against Group B Streptococcus | p. 289 |
Vaccines Against Streptococcus pneumoniae | p. 303 |
Veterinary Vaccines with a Focus on Bovine Mastitis | p. 329 |
Vaccines Against Newly Emerging Viral Diseases: the Example of SARS | p. 353 |
Index | p. 373 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.